These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8265124)

  • 1. [Immunotherapy of superficial bladder tumors in a hospital department].
    Prekopp G; Rosdy E
    Orv Hetil; 1993 Dec; 134(50):2757-60. PubMed ID: 8265124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
    Romics I; Dietmar B; Christoph R
    Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant BCG immunotherapy in the management of superficial bladder tumors].
    Somogyi L; Szántó A; Polyák L; Baranyay F; Drinóczy M
    Orv Hetil; 1993 Aug; 134(34):1851-6. PubMed ID: 8355975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
    Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy.
    Hurle R; Losa A; Ranieri A; Graziotti P; Lembo A
    J Urol; 1996 Nov; 156(5):1602-5. PubMed ID: 8863547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].
    Rivera P; Caffarena E; Cornejo H; Del Pino M; Fonerón A; Haemmersli J; Sepúlveda M; Ubilla A
    Actas Urol Esp; 1993 Apr; 17(4):243-6. PubMed ID: 8342414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Repeated yearly BCG treatment in superficial bladder cancer].
    Somogyi L; Török A; Bors G; Drinóczy M; Horváth R
    Orv Hetil; 1989 Mar; 130(13):671-3. PubMed ID: 2726237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The intravesical administration of BCG vaccine in treating recurrent superficial bladder cancer].
    Panteleeva ES; Neprina GS; Vatin OE; Kariakin OB; Safiullin KN
    Urol Nefrol (Mosk); 1997; (2):29-32. PubMed ID: 9206879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical immunotherapy with BCG in the adjuvant treatment of superficial bladder tumors--15-year-experience].
    Geavlete P; Georgescu D; Arabagiu I
    Chirurgia (Bucur); 2000; 95(2):157-68. PubMed ID: 14768319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylaxis of superficial bladder cancer with 1 mg of intravesical BCG: comparison with other doses].
    Corti Ortíz D; Rivera Garay P; Avilés Jasse J; Hidalgo Carmona F; MacMillan Soto G; Coz Cañas LF; Vargas Delaunoy R; Susaeta Saénz de San Pedro R
    Actas Urol Esp; 1993 Apr; 17(4):239-42. PubMed ID: 8342413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
    Korovin AI; Savvin VT
    Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCG in superficial carcinoma of the bladder. Authors' experience].
    Bordalba Gómez JR; Muñoz Segui J; Aguilo F; Gil Vernet A; Vigues F; Lopez Costea MA; Serrallach N
    Actas Urol Esp; 1992 Jun; 16(6):443-5. PubMed ID: 1509911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine].
    Bretheau D; Lechevallier E; Rossi D; Albert P; de Fromont M; Coulange C
    Prog Urol; 1993; 3(4):608-17. PubMed ID: 8401621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG].
    Ayed M; Ben Hassine L; Ben Slama R; Chelbi N; Ghozzi S; Drissi H; Jemni M; Chebil M
    Prog Urol; 1998 Apr; 8(2):206-10. PubMed ID: 9615929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.